Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | André Pèlegrin |
|---|---|
| Group name | EquipeAP |
| Item Type | Attachment |
| Title | Texte intégral |
| URL | https://www.tandfonline.com/doi/pdf/10.1080/19420862.2019.1612691?needAccess=true |
| Accessed | 2020/02/17 - 12:33:08 |
| Date Added | 2020/02/17 - 11:33:08 |
| Date Modified | 2020/02/17 - 11:33:08 |
| Parent item | Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6th antibody industrial symposium, June 25-26, 2018, Montpellier, France |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de